Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in IMMX — Immix Biopharma, Inc.

CIK 1214717 BOSTON, MA
Back to IMMX Full portfolio

Position in IMMX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$12,383,309
+$8,161,881 QoQ
Shares Held
1,201,097
+159.2% QoQ
Ownership
1.68%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 109 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMMX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. IMMX ranks #174 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in IMMX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,383,309 1,201,097
2026-03-31 $4,221,428 463,384
2025-12-31 $1,286,872 246,056
2025-09-30 $391,823 187,476
2025-06-30 $333,507 161,115
2025-03-31 $270,046 160,742
2024-12-31 $330,179 150,082
2024-09-30 $223,621 150,082
2024-06-30 $281,412 142,128
2024-03-31 $383,043 124,770
2023-12-31 $577,314 83,427
2023-09-30 $249,735 73,022
2023-06-30 $162,276 60,326
2023-03-31 $145,094 79,722
2022-12-31 $175,269 76,537
2022-09-30 $104,405 76,769
2022-06-30 $190,665 73,333